Clarithromycin in treatment of early lyme disease: A pilot study

被引:23
作者
Dattwyler, RJ
Grunwaldt, E
Luft, BJ
机构
关键词
D O I
10.1128/AAC.40.2.468
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Forty-one patients with erythema migrans were enrolled in an open-labelled pilot study of oral clarithromycin, 500 mg twice daily for 21 days, for the treatment of early Lyme disease. Immediately posttherapy, pretreatment signs and symptoms resolved among 91% of the 33 evaluable patients. At 6 months, all 28 of the evaluable patients were well. Clarithromycin shows promise as an effective agent for the treatment of early Lyme disease and warrants further study.
引用
收藏
页码:468 / 469
页数:2
相关论文
共 13 条
[1]   EFFICACY OF CLARITHROMYCIN FOR TREATMENT OF EXPERIMENTAL LYME-DISEASE INVIVO [J].
ALDER, J ;
MITTEN, M ;
JARVIS, K ;
GUPTA, P ;
CLEMENT, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (06) :1329-1333
[2]   TREATMENT OF ERYTHEMA CHRONICUM MIGRANS OF LYME-DISEASE [J].
BERGER, BW .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1988, 539 :346-351
[3]  
BERGER BW, 1993, SEMIN DERMATOL, V12, P357
[4]  
Buchstein S R, 1991, Infect Dis Clin North Am, V5, P103
[5]   AMOXYCILLIN PLUS PROBENECID VERSUS DOXYCYCLINE FOR TREATMENT OF ERYTHEMA MIGRANS BORRELIOSIS [J].
DATTWYLER, RJ ;
VOLKMAN, DJ ;
CONATY, SM ;
PLATKIN, SP ;
LUFT, BJ .
LANCET, 1990, 336 (8728) :1404-1406
[6]  
GROSS B, 1989, EUR J CLIN MICROBIOL, V8, P651
[7]  
HOVMARK A, 1990, 4 P INT C LYM BORR S, P161
[8]   INVITRO AND INVIVO SUSCEPTIBILITY OF BORRELIA-BURGDORFERI TO AZITHROMYCIN [J].
JOHNSON, RC ;
KODNER, C ;
RUSSELL, M ;
GIRARD, D .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1990, 25 :33-38
[9]   TREATMENT OF EARLY LYME-DISEASE [J].
MASSAROTTI, EM ;
LUGER, SW ;
RAHN, DW ;
MESSNER, RP ;
WONG, JB ;
JOHNSON, RC ;
STEERE, AC .
AMERICAN JOURNAL OF MEDICINE, 1992, 92 (04) :396-403
[10]   COMPARATIVE ANTIMICROBIAL ACTIVITY OF THE NEW MACROLIDES AGAINST BORRELIA-BURGDORFERI [J].
PREACMURSIC, V ;
WILSKE, B ;
SCHIERZ, G ;
SUISS, E ;
GROSS, B .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1989, 8 (07) :651-653